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Received 17 September 2015; accepted 26 October 2015A 74-year-old woman with left lumbar backache
visited her primary care doctor. A radiograph of her
abdomen was normal, but a radiograph of her chest
revealed multiple pulmonary inﬁltrates, and she was
referred to our institution. The results of positron
emission tomography/computed tomography (PET/
CT) scans revealed ﬂuorodeoxyglucose (FDG) uptake
of her gastric wall and multiple pulmonary nodules.
Although she was initially diagnosed with lung me-
tastases from gastric cancer, upper gastrointestinal
endoscopy revealed no lesions around her gastric site.
On the other hand, specimens obtained from the
pulmonary lesion by bronchoscopy showed thyroid
transcription factor 1 (TTF-1)–negative mucinous
adenocarcinoma with lepidic growth, which had no
epidermal growth factor receptor gene mutation
(Fig. 1), and she was diagnosed with adenocarcinoma.
Retroperitoneal ﬁbrosis was also part of the differen-
tial diagnosis, because the contrast-enhanced CT scanFigure 1. Mucinous adenocarcinoma with a lepidic growth
pattern (hematoxylin–eosin stain; low-power ﬁeld).
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her aorta and left hydronephrosis (Fig. 2A), and the
PET/CT scan revealed FDG uptake of the retroperito-
neal lesions (Fig. 2B). Because secondary retroperito-
neal ﬁbrosis caused by malignancy was included in the
differential diagnosis, a biopsy specimen of the retro-
peritoneal lesion was obtained. The biopsy specimen
revealed cytokeratin-7–positive and TTF-1–negative
adenocarcinoma with accumulation of mucus in the
duct of the gland (Fig. 3). Because tissue samples from
pulmonary lesions resembled those from retroperito-
neal lesions in both microscopic and immunohisto-
chemical staining ﬁndings, she was diagnosed with
retroperitoneal metastases from lung adenocarcinoma.
Her disease progressed in spite of the administration
of systemic chemotherapy using a platinum-based
combination regimen, and she died 130 days after
her ﬁrst diagnosis.
Retroperitoneal ﬁbrosis is rare. The idiopathic form
of the disease accounts for more than two-thirds of
cases, with the rest being caused by other factors.
Secondary retroperitoneal ﬁbrosis is caused by drugs,
infections, malignant diseases, and connective tissue
disease.1 Malignant diseases include carcinoma of the
colon, prostate, breast, and stomach, sarcomas, and*Corresponding author.
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Figure 2. A contrast-enhanced computed tomography scan revealed a shaggy lesion around the aorta (A). The lesion had high
integration of ﬂuorodeoxyglucose (B).
Figure 3. A retroperitoneal biopsy specimen revealed isolated ducts formation, the accumulation of mucus within ducts, and
a desmoplastic reaction. (Hematoxylin–eosin stain. A, low-power ﬁeld; B, high-power ﬁeld.)
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patients have the mass-forming type,3 but retroperito-
neal metastasis mimicking retroperitoneal ﬁbrosis
presenting with poorly marginated soft tissue density
around the aorta, as seen in our patient, is rare.
Because treatment of active retroperitoneal ﬁbrosis is
different from that of retroperitoneal metastasis caused
by lung cancer, an accurate diagnosis is important.References
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